Align business goals and improve patient care.
Overview:
In short, pharmaceutical or life science companies don’t have to fund services, but many choose to, because it aligns business goals with improving patient care and addressing system gaps.
Established collaborations with primary care structures across the UK enable PeopleWith to initiate clinical services for life science and pharmaceutical companies.
Clinical services available:
Improve Patient outcomes:
Pharma companies operate in therapy areas where:
- Disease burden is high
- Diagnosis and management gaps exist
- NHS resources are stretched
Funding services helps:
- Identify undiagnosed patients
- Ensure more people get guideline-based care
- Reduce avoidable complications
Address capacity gaps in Primary care:
Primary care is under intense workload pressure (chronic disease workload, recruitment gaps).
Pharmaceutical companies can fund:
- Extra clinics
- Audit and recall programmes
- Training and education
This helps practices deliver work they don’t have capacity for.
Support earlier uptake of Guidelines:
While pharmaceutical companies cannot promote prescribing directly through these services, they can:
- Provide education on NICE guidelines
- Support reviews that lead clinicians to consider all evidence-based options (some of which may include their products)
- Help practices embed care pathways faster
Important:
Prescribing decisions always remain with the clinician, but raising awareness of guidelines and improving identification indirectly supports uptake of appropriate treatments.
Align with NHS priorities and policy:
NHS England increasingly encourages collaborative working to:
- Improve prevention
- Reduce health inequalities
- Meet Long Term Plan ambitions (e.g., CVD prevention, earlier cancer diagnosis)
Pharmaceutical companies can support with funding, project management and disease area expertise which supports NHS strategic goals.
Build trust and partnerships:
Joint working and funded services help companies:
- Build relationships with NHS systems
- Understand real-world challenges
- Demonstrate corporate social responsibility
Done properly, these projects are clearly non-promotional, transparent, and win–win. Comply with ABPI and avoid direct promotion because directly incentivising prescribing is prohibited, the compliant route is:
- Funding services that improve care across the disease area
- Keeping all prescribing decisions with NHS clinicians
- Declaring funding transparently via ABPI Disclosure
Through established collaborations with primary care networks, PeopleWith to implement and support with clinical services for life science and pharmaceutical companies.
Contact us today.
